How to Disrupt the Health Care Industry (Take a Lesson From Home Care)

Silicon Valley tends to see the disruption of the multi-trillion-dollar, slow-moving health care industry as “inevitable.” Yet, startups promising to reinvent how we deliver care, perform procedures, or fight disease have fallen short — sometimes disastrously so.

In his recent piece, “There’s No Magic in Venture-Backed Home Care,” the CEO of HomeHero, Kyle Hill, describes his tech startup’s ultimately unsuccessful effort to disrupt what might be considered the traditional home care industry: employer-based private-pay home care. The article points to many challenges, including strict regulations, fierce competition, and limited reimbursement for home care. But HomeHero’s story reveals a more fundamental reality: tech alone can’t disrupt health care.

The fall of the digital health disruptor isn’t a fluke. It’s based in health care’s essential nature and resulting structure, which prioritizes well-being, quality of life, safety, and human relationships, instead of price or convenience.

More Than Just Inefficiencies

HomeHero shared the view — ever-present in the tech industry — that high-touch customer relationships, extensive caregiver training, and tax and regulatory requirements are merely inefficiencies. Again and again, tech startups fail to consider the value of these central elements of health care, and instead seek to bypass them.
In fact, there are often compelling reasons for these measures. In the home care industry, we see many supposed “inefficiencies” as important tools and safeguards that protect our loved ones. These measures help achieve our number one objective: building personal service and relationships that ensure high-quality outcomes and improve quality of life for our clients and their families.

Indeed, as the title of Mr. Hill’s article notes, there is magic in home care. But that magic is in repeated, consistent, and caring human interactions. Experienced home care companies working at a local level are expressly designed, staffed, and prepared to provide that service.

Why Tech Alone Can’t Disrupt Home Care

In particular, there are a few essential reasons why home care is so difficult to disrupt:

  • High-touch beats high-tech.

Flashier apps, better algorithms, and smarter sensors will never replace the personal relationships that home care professionals develop with families. These connections often last for years, offering consistency and trust that established home care companies are well-positioned to provide. While tech will certainly make home care more efficient — we are adopting these tools every day — it cannot replicate or sidestep the sense of security that our caregivers deliver.

  • High-quality care is not a commodity.

The contractor model works for some startups because the service is simple: arrive at point B in one piece, for example. But home care is far more complex, and it has higher stakes. Home care companies that employ their caregivers are required to comply with all applicable licensing and labor laws. They train their caregivers. They provide a dependable, reliable supply of them to their clients. And in doing all these things, they give you peace of mind and security. To provide the best care possible, a skilled caregiver must address a vast range of factors, needs, and choices, which vary for each client. Do you really want a company “eliminating inefficiencies” on regulations and labor laws when caring for your relative? When loved ones make home care decisions, they place an indescribable value on an older relative’s safety and well-being. They demand the certainty of the employer model.

  • Home care is already disruptive.

This is our best-kept secret: home care companies are some of the biggest disruptors in today’s health care industry. Home care meets the preferences of 9/10 seniors to age at home, for roughly half the cost of care in a nursing home, while also saving the US billions in hospital costs. One study showed the savings to be as high as $25 billion due to the growth of home care services in the early years of the industry. Home care fills a role that hospitals, nursing homes, and in many cases, families, simply may not have the capacity or skills to provide. But this disruption is based on people, relationships, and an innovative model of care — not just new technology.

Let’s Collaborate

The HomeHero team should be applauded for their work. It’s clear that Mr. Hill has pure intentions and a personal connection with the mission of home care. And I understand and share his desire to spread the advantages of home care to every American family.

We always welcome innovation to complement home care. From sensors to apps helping home care companies run more efficiently, there is a place for technology in home care. So I’d like to ask Mr. Hill and other entrepreneurs to join with the home care industry. Let’s team up to continue disrupting long-term and medical care, improve millions of lives, create jobs, and reduce health care costs.

The need for home care is enormous and growing rapidly, so both home care and tech companies can thrive. The ratio of potential family caregivers to people over-80 will be cut roughly in half by 2050, driving a spike in demand for professional caregivers. Our nation needs home care, and accompanying tech innovations, more than ever. There’s so much business opportunity — enough for all of us to benefit and do more work to help protect and serve America’s seniors.

Home care companies are already delivering the mix of commercial viability and social good that Silicon Valley has always prized. We have done this by staying true to a set of core approaches, some of which go beyond the bare bones of efficiency. But by working with emerging tech innovators, we can amplify our industry’s benefits, share our ideas, and improve our services.

Let’s work together to seize the enormous promise that home care continues to offer.

Phil Bongiorno is the Executive Director of the Home Care Association of America.

Source: Medium

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.